Exosomes derived from human amniotic epithelial cells accelerate diabetic wound healing via PI3K-AKT-mTOR-mediated promotion in angiogenesis and fibroblast function

Abstract

Background: Diabetic wounds are one of the most common and serious complications of diabetes mellitus, characterized by the dysfunction of wound-healing-related cells in quantity and quality. Our previous studies revealed that human amniotic epithelial cells (hAECs) could promote diabetic wound healing by paracrine action. Interestingly, numerous studies demonstrated that exosomes derived from stem cells are the critical paracrine vehicles for stem cell therapy. However, whether exosomes derived from hAECs (hAECs-Exos) mediate the effects of hAECs on diabetic wound healing remains unclear. This study aimed to investigate the biological effects of hAECs-Exos on diabetic wound healing and preliminarily elucidate the underlying mechanism. Methods: hAECs-Exos were isolated by ultracentrifugation and identified by transmission electron microscopy, dynamic light scattering and flow cytometry. A series of in vitrofunctional analyses were performed to assess the regulatory effects of hAECs-Exos on human fibroblasts (HFBs) and human umbilical vein endothelial cells (HUVECs) in a high-glycemic microenvironment. High-throughput sequencing and bioinformatics analyses were conducted to speculate the related mechanisms of actions of hAECs-Exos on HFBs and HUVECs. Subsequently, the role of the candidate signaling pathway of hAECs-Exos in regulating the function of HUVECs and HFBs, as well as in diabetic wound healing, was assessed. Results: hAECs-Exos presented a cup-or sphere-shaped morphology with a mean diameter of 105.89 ± 10.36 nm, were positive for CD63 and TSG101 and could be internalized by HFBs and HUVECs. After that, hAECs-Exos not only significantly promoted the proliferation and migration of HFBs, but also facilitated the angiogenic activity of HUVECs in vitro. High-throughput sequencing revealed enriched miRNAs of hAECs-Exos involved in wound healing. Kyoto Encyclopedia of Genes and Genomes and Gene Ontology analyses have shown that the target genes of the top 15 miRNAs were highly enriched in the PI3K-AKT pathway. Further functional studies demonstrated that the PI3K-AKT-mTOR pathway was necessary for the induced biological effects of hAECs-Exos on HFBs and HUVECs, as well as on wound healing, in diabetic mice. Conclusions: Our findings demonstrated that hAECs-Exos represent a promising, novel strategy for diabetic wound healing by promoting angiogenesis and fibroblast function via activation of the PI3K-AKT-mTOR pathway.

Keywords

Human amniotic epithelial cells / Exosomes / Diabetic wound healing / PI3K-AKT-mTOR

References

[1] Patel S, Srivastava S, Singh MR, Singh D. Mechanistic insight into diabetic wounds: pathogenesis, molecular targets and treatment strategies to pace wound healing. Biomed Pharmacother. 2019. doi: 10.1016/j.biopha.2019.108615.

[2] Snyder RJ, Kirsner RS, Warriner RA, Lavery LA, Hanft JR, Sheehan P. Consensus recommendations on advancing the standard of care for treating neuropathic foot ulcers in patients with diabetes. Ostomy Wound Manage. 2010; 56: S1-24.

[3] Azar ND, Fatemeh MB, Mohammad C, Shiva RD. Skin tissue engineering: wound healing based on stem-cell-based therapeutic strategies. Stem Cell Res Ther. 2019. doi: 10.1186/s13287-019-1212-2.

[4] Akle CA, Adinolfi M, Welsh KI, Leibowitz S, Mccoll I. Immunogenicity of human amniotic epithelial cells after transplantation into volunteers. Lancet. 1981; 2: 1003-5.

[5] Zheng Y, Zheng S, Fan X, Li L, Xiao Y, Luo P, et al. Amniotic epithelial cells accelerate diabetic wound healing by modulating inflammation and promoting neovascularization. Stem Cells Int. 2018. doi: 10.1155/2018/1082076.

[6] Herberts CA, Kwa MS, Hermsen HP. Risk factors in the development of stem cell therapy. J Transl Med. 2011; 9: 29.

[7] Cabral J, Ryan A, Griffin M, Ritter T. Extracellular vesicles as modulators of wound healing. Adv Drug Deli Rev. 2018; 129: 394-406.

[8] Gurunathan S, Kang M, Jeyaraj M, Qasim M, Kim J. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of Exosomes. Cells. 2019; 8: 307-43.

[9] Yang X, Sun C, Wang L, Guo X. New insight into isolation, identification techniques and medical applications of exosomes. Cell. 2019; 308: 119-29.

[10] Zhang J, Chen C, Hu B, Niu X, Liu X, Zhang G, et al. Exosomes derived from human endothelial progenitor cells accelerate cutaneous wound healing by promoting angiogenesis through Erk1/2 signaling. Int J Biol Sci. 2016; 12: 1472-87.

[11] Hu Y, Rao S, Wang Z, Cao J, Tan Y, Luo J, et al. Exosomes from human umbilical cord blood accelerate cutaneous wound healing through miR-21-3p-mediated promotion of angiogenesis and fibroblast function.Theranostics. 2018; 8: 169-84.

[12] Shabbir A, Cox A, Rodriguez-Menocal L, Salgado M, Badiavas EV. Mesenchymal stem cell Exosomes induce proliferation and migration of normal and chronic wound fibroblasts, and enhance angiogenesis in vitro. Stem Cells Dev. 2015; 24: 1635-47.

[13] Hu P, Yang Q, Wang Q, Shi C, Wang D, Armato U, et al. Mesenchymal stromal cells-exosomes: a promising cell-free therapeutic tool for wound healing and cutaneous regeneration. Burns Trauma. 2019. doi: 10.1186/s41038-019-0178-8.

[14] Zheng Y, Ji S, Wu H, Tian S, Wang X, Luo P, et al. Acceleration of diabetic wound healing by a cryopreserved living dermal substitute created by micronized amnion seeded with fibroblasts. Am J Transl Res. 2015; 7: 2683-93.

[15] Lv C, Duan H, Wang S, Gan L, Xu Q. Exosomes derived from human umbilical cord Mesenchymal stem cells promote proliferation of allogeneic endometrial stromal cells. Reprod Sci. 2020; 27: 1372-81.

[16] Zheng Y, Wang X, Ji S, Tian S, Wu H, Luo P, et al. Mepenzolate bromide promotes diabetic wound healing by modulating inflammation and oxidative stress. Am J Transl Res. 2016; 8: 2738-47.

[17] Liu T, Qiu C, Ben C, Li H, Zhu S. One-step approach for full-thickness skin defect reconstruction in rats using minced split-thickness skin grafts with Pelnac overlay. Burns Trauma. 2019. doi: 10.1186/s41038-019-0157-0.

[18] Fang S, Xu C, Zhang Y, Xue C, Yang C, Bi H, et al. Umbilical cord-derived Mesenchymal stem cell-derived Exosomal MicroRNAs suppress Myofibroblast differentiation by inhibiting the transforming growth factor-β/SMAD2 pathway during wound healing. Stem Cell Transl Med. 2016; 5: 1425-39.

[19] Liu M, Liu T, Zhang X, Jian Z, Xia H, Yang J, et al. Fabrication of KR-12 peptide-containing hyaluronic acid immobilized fibrous eggshell membrane effectively kills multi-drug-resistant bacteria, promotes angiogenesis and accelerates re-epithelialization. Int J Nanomed. 2019; 14: 3345-60.

[20] Darby IA, Laverdet B, Bonté F, Desmouliére A. Fibroblasts and myofibroblasts in wound healing. Clin Cosmet Investig Dermatol. 2014; 7: 301-11.

[21] Khamaisi M, Katagiri S, Keenan H, Park K, Maeda Y, Li Q, et al. PKC δinhibition normalizes the wound-healing capacity of diabetic human fibroblasts. J. Clin. Investig. 2016; 126: 837-53.

[22] Loots MA, Lamme EN, Mekkes JR, Bos JD, Middelkoop E. Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation. Arch Dermatol Res. 1999; 291: 93-9.

[23] Mizoguchi T, Ueno K, Yanagihara M, Samura M, Kurazumi H, Suzuki R, et al. Autologous fibroblasts, peripheral blood mononuclear cells, and fibrin glue accelerate healing of refractory cutaneous ulcers in diabetic mice. Am J Transl Res. 2018; 10: 2920-8.

[24] Martin A, Komada MR, Sane DC. Abnormal angiogenesis in diabetes mellitus. Med Res Rev. 2003; 23: 117-45.

[25] Syed SN, Brüne B. MicroRNAs as emerging regulators of signaling in the tumor microenvironment. Cancers. 2020; 12: 911.

[26] Xiao G, Cheng C, Chiang Y, Cheng W, Liu I, Wu S. Exosomal miR-10a derived from amniotic fluid stem cells preserves ovarian follicles after chemotherapy. Sci Rep. 2016; 6: 23120.

[27] Fortunato O, Gasparini P, Boeri M, et al. Exo-microRNAs as a new tool for liquid biopsy in lung cancer. Cancers. 2019; 11: 888-903.

[28] Zhao B,Li X,Shi X,Shi X,Zhang W,Wu G, et al. Exosomal MicroRNAs derived from human amniotic epithelial cells accelerate wound healing by promoting the proliferation and migration of fibroblasts. Stem Cells Int. 2018. doi: 10.1155/2018/5420463.

[29] Yang X, Wang J, Guo S, Fan K, Li J, Wang Y, et al. miR-21 promotes keratinocyte migration and re-epithelialization during wound healing. Int J Biol Sci. 2011; 7: 685-90.

[30] Wang T, Feng Y, Sun H, Zhang L, Hao L, Shi C, et al. miR-21 regulates skin wound healing by targeting multiple aspects of the healing process. Am J Pathol. 2012; 181: 1911-20.

[31] Madhyastha R, Madhyastha H, Nakajima Y, Omura S, Maruyama M. MicroRNA signature in diabetic wound healing: promotive role of miR-21 in fibroblast migration. Int Wound J. 2012; 9: 355-61.

[32] Jin Y, Tymen SD, Chen D, Fang ZJ, Zhao Y, Dragas D, et al. MicroRNA-99 family targets AKT/mTOR signaling pathway in dermal wound healing. PLoS One. 2013: e64434-42. doi: 10.1371/journal.pone.0064434.

[33] Xiong Y, Cao F, Hu L, Yan C, Chen L, Panayi AC, et al. microRNAs-26a-5p accelerates healing via Downregulation of PTEN in fracture patients with traumatic brain injury. Mol Ther-Nucl Acids. 2019; 17: 223-34.

[34] Zhang E, Gao B, Yang L, Wu X, Wang Z. Notoginsenoside Ft1 promotes fibroblast proliferation via PI3K/Akt/mTOR signaling pathway and benefits wound healing in genetically diabetic mice. J Pharmacol Exp Ther. 2016; 356: 324-32.

[35] Xiao W, Tang H, Wu M, Liao Y, Li K, Li L, et al. Ozone oil promotes wound healing by increasing the migration of fibroblasts via PI3K/Akt/mTOR signaling pathway. Bioscience Rep. 2017. doi: 10.1042/BSR20170658.